New Product Opportunities-Having the Right Stuff to Win the Game

We are currently in the heart of the pro and college football season, so it’s time for some gridiron metaphors. This December edition of Specialty Pharmacy Times® (SPT®) crosses the goal line and into our seventh year. We continue to build our team and playbook, including our annual end-of-the-year new drug approval series.

This recurring feature is authored by Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, a leader at Managed Health Care Associates, Inc and contributing editor to SPT®, and her colleague, Ruby Mhajan, RPh. The pipeline of specialty products is robust, and each product approval has a story and opportunity built around it. The approach to managing the complex environment of specialty products must be both strategic and tactical if you want to compete, and each product has challenges and subsequent opportunities buried within them.

It takes hard work and thoughtful preparation to come up with the right game plan to ensure the best possible patient outcome. Each product requires a unique strategy, and frankly, that’s why we call it “specialty.”

The Rule Book
Essentially, there are 2 supply chain streams in specialty: open and limited. Although open distribution products create access to revenue opportunities, a specialty pharmacy may need to dig a little deeper with manufacturers to be compensated for services and data in exchange for the value manufacturers subsequently return to pharmacies and patients.

Opportunities do exist, just ask around. Are you participating in any business development efforts or attending the right conferences to engage, such as NASP, Asembia, or sPCMA?

Limited distribution products, as a rule, have services built in to their agreements. When picking their roster of network providers, manufacturers should be running the right drills and exploring all of the ways to fill the gaps with their products to ensure they have the right mix of players on the field. Also, they should make sure their bench has the right players in case there is a need to have a stronger lineup.

Launch planning in the preseason, prior to a drug is approved by the FDA, is key. Having a process to statistically measure the right performance and objectively score the best roster is important, but equally important is having intuition and experience. Which leads us to the question: does your specialty pharmacy have the right stuff to compete and deliver value to get you in the game?

We are well into the era in which a significant number of approvals will potentially be offered to a limited number of specialty pharmacies. To have a chance, it is critical that specialty pharmacies have an optimal game plan in place.



Building the Value Proposition for Specialty
The highly-customizable platform that specialty provides to manufacturers is very dynamic, and depending on the nuances of the product, there are many lineups (services) that can be deployed. In the figure above, I’ve detailed 8 distinct areas, all of which can stand on their own in providing value to supporting a specialty product.

Within each of these 8 areas, there are many substantial opportunities. However they are employed, this mixture of services creates a power set of deliverables to help bring victory. Think of each of these areas as positions on the field akin to key members of your team.

With one player missing, gaps are created, and this weakness could expose your overall offering and potentially throw you for a loss. When they all come together, however, your offering can be unbeatable.

Selecting Your Disease State and Playing the Field
Many pharmacies have sub-specialized in key therapeutic areas and become experts at providing services for those products that treat specific disease states. Like physicians, pharmacy specialists strive to be the best at managing patients with their medications in specific disease states. Other pharmacies may, however, work across a portfolio of disease states with teams of specialists.

Lastly, others may be full generalists or multi-sport athletes. It’s been my observation that for at least the nonpayer-owned specialty pharmacies, success has come with a more defined focus on disease/product-specific services.

If specialty pharmacies aspire to be national in scope and reach the top of the power polls, concentrate on disease areas that fit the portfolio of expertise you can build with your teams. It is critical that you deploy account managers in the field, calling on both payers and prescribers to tell your story.

Locally managed specialty pharmacies can be powerhouses in and of themselves and often have the advantage of geography and face-to-face relationships with providers that are in their specific markets, as referrals often come from having those personal relationships in place. Think of when you see your doctor and need a referral to a specialist.

They are more likely to point you to a colleague with whom they’ve worked side by side; well, the same can go with a specialty pharmacy.



Most Popular

Related Articles

Specialty Pharmacy Times expands Strategic Alliance Partnership program with two new organizations.
Guidance intends to help sponsors demonstrate Interchangeability with a reference product.
Remaining special in the specialty pharmacy space requires innovation.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
HCPLive
ONCLive
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Intellisphere, LLC. All Rights Reserved.